Kyowa Kirin

Chiyoda, Japan Founded: 1949 • Age: 77 yrs
Developer of biologics for multiple diseases and disorders

About Kyowa Kirin

Kyowa Kirin is a company based in Chiyoda (Japan) founded in 1949.. Kyowa Kirin has completed 1 acquisition, including Orchard Therapeutics. Kyowa Kirin operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

  • Headquarter Chiyoda, Japan
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $13.64 K (USD)
    0
    as on Aug 31, 2021
  • Net Profit
    $-1.12 K (USD)
    -90
    as on Aug 31, 2023
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Kyowa Kirin
Headcount 5000-10000
Employee Profiles 54
Board Members and Advisors 7
Employee Profiles
People
Atsushi Matsumoto
Global Supply Chain Management Head
People
Masashi Miyamoto
President, CEO & Executive Director
People
Yoshifumi Torii
Global Research Head
People
Yutaka Osawa
Chief Compliance Officer

Unlock access to complete

Board Members and Advisors
people
Yuko Haga
Director
people
Akira Morita
Director
people
Tomomi Yatsu
Supervisory Board Member
people
Toru Ishikura
Board Member

Unlock access to complete

Funding Insights of Kyowa Kirin

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Kyowa Kirin

Kyowa Kirin has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orchard Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Ex-vivo gene therapies for rare orphan diseases are developed.
2015
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Kyowa Kirin

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kyowa Kirin Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kyowa Kirin

Kyowa Kirin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Cancer therapies are developed using selective pathway inhibitors.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Kyowa Kirin

When was Kyowa Kirin founded?

Kyowa Kirin was founded in 1949.

Where is Kyowa Kirin located?

Kyowa Kirin is headquartered in Chiyoda, Japan. It is registered at Chiyoda, Tokyo, Japan.

Who is the current CEO of Kyowa Kirin?

Nobuo Hanai is the current CEO of Kyowa Kirin.

What is the annual revenue of Kyowa Kirin?

Annual revenue of Kyowa Kirin is $13.64K as on Aug 31, 2021.

What does Kyowa Kirin do?

Developer of biologics for multiple diseases and disorders. The company develops next-generation drugs, nucleic-acid drugs, and regenerative medicine. The product portfolio includes Abstral, brodalumab, PecFent, coniel, and more.

Who are the top competitors of Kyowa Kirin?

Kyowa Kirin's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

How many acquisitions has Kyowa Kirin made?

Kyowa Kirin has made 1 acquisition, including Orchard Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available